Genes & Health QMUL KCL costs

Trembath, Richard (Primary Investigator)

Medical & Molecular Genetics

Project: Research

Status	Active
Effective start/end date	18/10/2021 → 17/10/2025

Collaborative partners

King's College London (lead)
Novo Nordisk A/S
Maze Therapeutics, Inc.
Merck Sharp & Dohme Corp
Bristol-Myers Squibb Company
Takeda Pharmaceuticals International
Pfizer Inc.
AstraZeneca AB
Glaxo Wellcome Research & Development Ltd

Funding

Queen Mary University of London: £958,231.01